T Rowe Price Group

TROW · NASDAQ

$102.13+$2.03 (+2.03%)TodayMarket closed ·
Prev close $100.10

TROW analyst rating

HoldConsensus of 11 analysts over the last 12 months. 0% rate it a buy.
  • Strong buy0
  • Buy0
  • Hold7
  • Underperform3
  • Sell1

12-month price target · 14 analysts

Average $109.45 (+7.2% upside)

Low
$90.90
Now
$102.13
High
$130.20

Upgrades and downgrades

The latest rating actions, newest first

TROW analyst upgrades, downgrades and rating actions
FirmDateActionRating
BarclaysOct 14, 2026MaintainsUnderweight
JP MorganOct 13, 2026MaintainsUnderweight
BMO CapitalOct 13, 2026MaintainsMarket Perform
TD CowenOct 12, 2026MaintainsHold
Evercore ISI GroupOct 9, 2026MaintainsIn-Line
UBSOct 7, 2026InitiatesSell → Neutral
Morgan StanleySep 25, 2026MaintainsEqual-Weight
Evercore ISI GroupSep 9, 2026MaintainsIn-Line
TD CowenAug 31, 2026MaintainsHold
Evercore ISI GroupAug 10, 2026MaintainsIn-Line

The case for and against

Updated Jan 19, 2026

Bull case

T. Rowe Price Group has demonstrated a positive shift in its financial projections, with 2026 estimates benefiting from increased investment advisory fees, adjusted revenues, and a reduced share count, despite some pressures from administrative fees and compensation expenses. The firm has also seen substantial growth in its exchange-traded funds (ETFs), generating net inflows of $2.5 billion in the second quarter, indicating strong market demand. Additionally, the firm's substantial assets under management, totaling $1.767 trillion—with a significant portion in retirement-based accounts—underscore its stable client base and potential for sustained growth.

Bear case

T. Rowe Price Group faced challenges in its investment advisory segment, reporting a miss of $0.11 per share driven by a decline in average assets under management (AUM), which could signal potential losses in revenue stability. The company's core fee rate, excluding performance fees, was marginally below expectations at 0.396%, further indicating possible pressures on its revenue model. Additionally, unexpected deterioration in operating margins raises concerns about future earnings and valuation, implying a negative outlook for the firm's financial health.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.